Correlation Between Microsoft and Medtech Acquisition
Can any of the company-specific risk be diversified away by investing in both Microsoft and Medtech Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Medtech Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Medtech Acquisition Corp, you can compare the effects of market volatilities on Microsoft and Medtech Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Medtech Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Medtech Acquisition.
Diversification Opportunities for Microsoft and Medtech Acquisition
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Microsoft and Medtech is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Medtech Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medtech Acquisition Corp and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Medtech Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medtech Acquisition Corp has no effect on the direction of Microsoft i.e., Microsoft and Medtech Acquisition go up and down completely randomly.
Pair Corralation between Microsoft and Medtech Acquisition
If you would invest 43,440 in Microsoft on September 20, 2024 and sell it today you would earn a total of 263.00 from holding Microsoft or generate 0.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Microsoft vs. Medtech Acquisition Corp
Performance |
Timeline |
Microsoft |
Medtech Acquisition Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Microsoft and Medtech Acquisition Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Microsoft and Medtech Acquisition
The main advantage of trading using opposite Microsoft and Medtech Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Medtech Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medtech Acquisition will offset losses from the drop in Medtech Acquisition's long position.Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |